Primary prevention of coronary artery disease among middle aged men in Prague:: Twenty-year follow-up results

被引:15
|
作者
Boudík, F
Reissigová, J
Hrach, K
Tomecková, M
Bultas, J
Anger, Z
Aschermann, M
Zvárová, J
机构
[1] Charles Univ Hosp, Dept Internal Med 2, Prague 2, Czech Republic
[2] Acad Sci Czech Republ, ICS, EurMISE Ctr Cardio, Prague, Czech Republic
关键词
primary prevention study; atherosclerosis; cardiovascular diseases; coronary artery disease; Framingham risk function; mortality; risk factors;
D O I
10.1016/j.atherosclerosis.2005.02.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Coronary artery disease (CAD) represents the most common cause of morbidity and mortality in the Czech Republic. The aim of this study is to analyze long-term cardiovascular diseases (CVD) mortality, identify predictors of outcome and to validate the Framingham risk function in men from the Czech Republic. Design and methods: A 20-year primary prevention study of atherosclerosis risk factors in 1417 men from Prague aged 38-53 years was launched in 1975 (STULONG). Results: When analyzing CVD mortality, heavy smokers had hazard higher than non-smokers and light smokers (p < 0.0001); hypertensives higher than normotensives (p < 0.0001); men with hypercholesterolemia higher than those with normal cholesterol (P = 0.0432), and university-educated men lower than elementary-educated men (p = 0.0006). In 1980-1984, the age specific mortality from CVD in men from STULONG was higher (p = 0.0132) than in the Czech Republic, in 1985-1994 insignificantly lower. The Framingham risk function underestimated the absolute 10-year risk of CAD across the quintile of the risk (p < 0.0001), with 63% discrimination. Conclusion: In STULONG, the mortality from CVD was significantly associated with known risk factors (hypertension, smoking, hypercholesterolemia, education); the Framingham risk function underestimated the absolute 10-year risk of CAD. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:86 / 93
页数:8
相关论文
共 50 条
  • [31] Twenty-year follow-up of hip problems in arthrogryposis multiplex congenita
    Yau, PWP
    Chow, W
    Li, YH
    Leong, JCY
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2002, 22 (03) : 359 - 363
  • [32] Alcohol consumption and mortality in Serbia: Twenty-year follow-up study
    Jakovljevic, B
    Stojanov, V
    Paunovic, K
    Belojevic, G
    Milic, N
    CROATIAN MEDICAL JOURNAL, 2004, 45 (06) : 764 - 768
  • [33] Twenty-year follow-up: an unusual case of nephropathy of antiphospholipid syndrome
    Lin, Y. Q.
    Lakshminarayanan, S.
    Yamase, H.
    Palmisano, J.
    Parke, A.
    LUPUS, 2009, 18 (06) : 564 - 566
  • [34] Twenty-year follow-up of osteosarcoma of the extremity treated with adjuvant chemotherapy
    Longhi, A
    Pasini, E
    Bertoni, F
    Pignotti, E
    Ferrari, C
    Bacci, G
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (06) : 582 - 588
  • [35] TWENTY-YEAR FOLLOW-UP OF NEWBORN SCREENING FOR PATIENTS WITH MUSCULAR DYSTROPHY
    Chung, Jeffrey
    Smith, Andrea L.
    Hughes, Sarah C.
    Niizawa, Gabriela
    Abdel-Hamid, Hoda Z.
    Naylor, Edwin W.
    Hughes, Timothy
    Clemens, Paula R.
    MUSCLE & NERVE, 2016, 53 (04) : 570 - 578
  • [36] College cheating: A twenty-year follow-up and the addition of an honor code
    Vandehey, Michael A.
    Diekhoff, George M.
    LaBeff, Emily E.
    JOURNAL OF COLLEGE STUDENT DEVELOPMENT, 2007, 48 (04) : 468 - 480
  • [37] A Twenty-Year Follow-up Study of Trabeculectomy: Risk Factors and Outcomes
    Landers, John
    Martin, Keith
    Sarkies, Nicholas
    Bourne, Rupert
    Watson, Peter
    OPHTHALMOLOGY, 2012, 119 (04) : 694 - 702
  • [38] Effects of father participation in child rearing: Twenty-year follow-up
    Williams, E
    Radin, N
    AMERICAN JOURNAL OF ORTHOPSYCHIATRY, 1999, 69 (03) : 328 - 336
  • [39] Five-year follow-up of drug utilization for secondary prevention in coronary artery disease
    Rabus, Sule Apikoglu
    Izzettin, Fikret V.
    Sancar, Mesut
    Karakaya, Osman
    Kargin, Ramazan
    Yakut, Cevat
    PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 753 - 758
  • [40] Five-year follow-up of drug utilization for secondary prevention in coronary artery disease
    Sule Apikoglu Rabus
    Fikret V. Izzettin
    Mesut Sancar
    Osman Karakaya
    Ramazan Kargin
    Cevat Yakut
    Pharmacy World & Science, 2008, 30 : 753 - 758